These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38605893)

  • 1. Activity against
    Alkaltham MF; Almansour AI; Arumugam N; Vagolu SK; Tønjum T; Alaqeel SI; Rajaratnam S; Sivaramakrishnan V
    RSC Adv; 2024 Apr; 14(17):11604-11613. PubMed ID: 38605893
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Dokrungkoon T; Tulyaprawat O; Suwannakarn K; Ngamskulrungroj P
    Front Microbiol; 2023; 14():1171861. PubMed ID: 37492259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from the USA.
    Guo H; Seet Q; Denkin S; Parsons L; Zhang Y
    J Med Microbiol; 2006 Nov; 55(Pt 11):1527-1531. PubMed ID: 17030912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial activities of spirooxindolopyrrolidine tethered dicarbonitrile heterocycles against multidrug resistant nosocomial pathogens.
    Arumugam N; Almansour AI; Suresh Kumar R
    J Infect Public Health; 2021 Dec; 14(12):1810-1814. PubMed ID: 34776342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regio- and diastereoselective synthesis of spiropyrroloquinoxaline grafted indole heterocyclic hybrids and evaluation of their anti-
    Arumugam N; Almansour AI; Kumar RS; Mohammad Ali Al-Aizari AJ; Alaqeel SI; Kansız S; Krishna VS; Sriram D; Dege N
    RSC Adv; 2020 Jun; 10(40):23522-23531. PubMed ID: 35517328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Characterization of the katG, inhA, ahpC, kasA, and oxyR gene mutations in isoniazid-resistant and susceptible strain of Mycobacterium tuberculosis by automated DNA sequencing].
    Chen X; Ma Y; Jin Q; Jiang GL; Li CY; Wang Q
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Apr; 28(4):250-3. PubMed ID: 15854436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Mutations Associated with Isoniazid Resistance in Mycobacterium tuberculosis in Mongolia.
    Narmandakh E; Tumenbayar O; Borolzoi T; Erkhembayar B; Boldoo T; Dambaa N; Burneebaatar B; Nymadawa N; Mitarai S; Jav S; Chiang CY
    Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32312782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, computational docking and molecular dynamics studies of a new class of spiroquinoxalinopyrrolidine embedded chromanone hybrids as potent anti-cholinesterase agents.
    Arumugam N; Darshan V M D; Venketesh V; Pradhan SS; Garg A; Sivaramakrishnan V; Kanchi S; Mahalingam SM
    RSC Adv; 2024 Jun; 14(26):18815-18831. PubMed ID: 38867740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of mutations associated with isoniazid resistance in multidrug-resistant Mycobacterium tuberculosis clinical isolates.
    Jagielski T; Bakuła Z; Roeske K; Kamiński M; Napiórkowska A; Augustynowicz-Kopeć E; Zwolska Z; Bielecki J
    J Antimicrob Chemother; 2014 Sep; 69(9):2369-75. PubMed ID: 24855126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variants of katG, inhA and nat genes are not associated with mutations in efflux pump genes (mmpL3 and mmpL7) in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from India.
    Unissa AN; Dusthackeer VNA; Kumar MP; Nagarajan P; Sukumar S; Kumari VI; Lakshmi AR; Hanna LE
    Tuberculosis (Edinb); 2017 Dec; 107():144-148. PubMed ID: 29050763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of the coexistence of non-codon 315 katG, inhA, and oxyR-ahpC intergenic gene mutations among isoniazid-resistant and multidrug-resistant isolates of Mycobacterium tuberculosis: a report of novel mutations.
    Norouzi F; Moghim S; Farzaneh S; Fazeli H; Salehi M; Nasr Esfahani B
    Pathog Glob Health; 2022 Feb; 116(1):22-29. PubMed ID: 34086544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mutations of katG and inhA genes of isoniazid-resistant Mycobacterium tuberculosis isolates in Taiwan.
    Tseng ST; Tai CH; Li CR; Lin CF; Shi ZY
    J Microbiol Immunol Infect; 2015 Jun; 48(3):249-55. PubMed ID: 24184004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inducing vulnerability to InhA inhibition restores isoniazid susceptibility in drug-resistant
    Harrison GA; Wang ER; Cho K; Mreyoud Y; Sarkar S; Almqvist F; Patti GJ; Stallings CL
    mBio; 2024 Mar; 15(3):e0296823. PubMed ID: 38294237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A virtual screen discovers novel, fragment-sized inhibitors of Mycobacterium tuberculosis InhA.
    Perryman AL; Yu W; Wang X; Ekins S; Forli S; Li SG; Freundlich JS; Tonge PJ; Olson AJ
    J Chem Inf Model; 2015 Mar; 55(3):645-59. PubMed ID: 25636146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereoselective synthesis and discovery of novel spirooxindolopyrrolidine engrafted indandione heterocyclic hybrids as antimycobacterial agents.
    Arumugam N; Almansour AI; Kumar RS; Siva Krishna V; Sriram D; Dege N
    Bioorg Chem; 2021 May; 110():104798. PubMed ID: 33735710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the katG and inhA genes of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis.
    Rouse DA; Li Z; Bai GH; Morris SL
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2472-7. PubMed ID: 8585728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic mutations in the katG, inhA and aphC genes are useful for the prediction of isoniazid resistance in Mycobacterium tuberculosis isolates from Kwazulu Natal, South Africa.
    Kiepiela P; Bishop KS; Smith AN; Roux L; York DF
    Tuber Lung Dis; 2000; 80(1):47-56. PubMed ID: 10897383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlating genetic mutations with isoniazid phenotypic levels of resistance in Mycobacterium tuberculosis isolates from patients with drug-resistant tuberculosis in a high burden setting.
    Pinhata JMW; Brandao AP; Mendes FF; Rabello MCDS; Ferrazoli L; de Oliveira RS
    Eur J Clin Microbiol Infect Dis; 2021 Dec; 40(12):2551-2561. PubMed ID: 34297229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of hybrid molecules as antimycobacterial compounds: Synthesis of isoniazid-naphthoquinone derivatives and their activity against susceptible and resistant strains of Mycobacterium tuberculosis.
    Reis WJ; Bozzi ÍAO; Ribeiro MF; Halicki PCB; Ferreira LA; Almeida da Silva PE; Ramos DF; de Simone CA; da Silva Júnior EN
    Bioorg Med Chem; 2019 Sep; 27(18):4143-4150. PubMed ID: 31378595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethionamide cross- and co-resistance in children with isoniazid-resistant tuberculosis.
    Schaaf HS; Victor TC; Venter A; Brittle W; Jordaan AM; Hesseling AC; Marais BJ; van Helden PD; Donald PR
    Int J Tuberc Lung Dis; 2009 Nov; 13(11):1355-9. PubMed ID: 19861006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.